Literature DB >> 16284649

Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents.

Katsutaro Morino1, Kitt Falk Petersen, Sylvie Dufour, Douglas Befroy, Jared Frattini, Nadine Shatzkes, Susanne Neschen, Morris F White, Stefan Bilz, Saki Sono, Marc Pypaert, Gerald I Shulman.   

Abstract

To further explore the nature of the mitochondrial dysfunction and insulin resistance that occur in the muscle of young, lean, normoglycemic, insulin-resistant offspring of parents with type 2 diabetes (IR offspring), we measured mitochondrial content by electron microscopy and insulin signaling in muscle biopsy samples obtained from these individuals before and during a hyperinsulinemic-euglycemic clamp. The rate of insulin-stimulated muscle glucose uptake was approximately 60% lower in the IR offspring than the control subjects and was associated with an approximately 60% increase in the intramyocellular lipid content as assessed by H magnetic resonance spectroscopy. Muscle mitochondrial density was 38% lower in the IR offspring. These changes were associated with a 50% increase in IRS-1 Ser312 and IRS-1 Ser636 phosphorylation and an approximately 60% reduction in insulin-stimulated Akt activation in the IR offspring. These data provide new insights into the earliest defects that may be responsible for the development of type 2 diabetes and support the hypothesis that reductions in mitochondrial content result in decreased mitochondrial function, which predisposes IR offspring to intramyocellular lipid accumulation, which in turn activates a serine kinase cascade that leads to defects in insulin signaling and action in muscle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16284649      PMCID: PMC1280967          DOI: 10.1172/JCI25151

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Prevention of fat-induced insulin resistance by salicylate.

Authors:  J K Kim; Y J Kim; J J Fillmore; Y Chen; I Moore; J Lee; M Yuan; Z W Li; M Karin; P Perret; S E Shoelson; G I Shulman
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment.

Authors:  Raghavakaimal Sreekumar; Panagiotis Halvatsiotis; Jill Coenen Schimke; K Sreekumaran Nair
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

3.  Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle.

Authors:  Chunli Yu; Yan Chen; Gary W Cline; Dongyan Zhang; Haihong Zong; Yanlin Wang; Raynald Bergeron; Jason K Kim; Samuel W Cushman; Gregory J Cooney; Bronwyn Atcheson; Morris F White; Edward W Kraegen; Gerald I Shulman
Journal:  J Biol Chem       Date:  2002-11-14       Impact factor: 5.157

4.  Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance.

Authors:  J K Kim; J J Fillmore; Y Chen; C Yu; I K Moore; M Pypaert; E P Lutz; Y Kako; W Velez-Carrasco; I J Goldberg; J L Breslow; G I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

5.  The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes.

Authors:  Adam B Mayerson; Ripudaman S Hundal; Sylvie Dufour; Vincent Lebon; Douglas Befroy; Gary W Cline; Staffan Enocksson; Silvio E Inzucchi; Gerald I Shulman; Kitt F Petersen
Journal:  Diabetes       Date:  2002-03       Impact factor: 9.461

6.  A central role for JNK in obesity and insulin resistance.

Authors:  Jiro Hirosumi; Gürol Tuncman; Lufen Chang; Cem Z Görgün; K Teoman Uysal; Kazuhisa Maeda; Michael Karin; Gökhan S Hotamisligil
Journal:  Nature       Date:  2002-11-21       Impact factor: 49.962

7.  AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation.

Authors:  Haihong Zong; Jian Ming Ren; Lawrence H Young; Marc Pypaert; James Mu; Morris J Birnbaum; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-20       Impact factor: 11.205

8.  Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes.

Authors:  Karim Bouzakri; Marina Roques; Philippe Gual; Sophie Espinosa; Fitsum Guebre-Egziabher; Jean-Paul Riou; Martine Laville; Yannick Le Marchand-Brustel; Jean-François Tanti; Hubert Vidal
Journal:  Diabetes       Date:  2003-06       Impact factor: 9.461

9.  Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha.

Authors:  Samar I Itani; Neil B Ruderman; Frank Schmieder; Guenther Boden
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

10.  Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts.

Authors:  Craig S Stump; Kevin R Short; Maureen L Bigelow; Jill M Schimke; K Sreekumaran Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

View more
  314 in total

1.  Mitochondrial H+-ATP synthase in human skeletal muscle: contribution to dyslipidaemia and insulin resistance.

Authors:  Laura Formentini; Alexander J Ryan; Manuel Gálvez-Santisteban; Leslie Carter; Pam Taub; John D Lapek; David J Gonzalez; Francisco Villarreal; Theodore P Ciaraldi; José M Cuezva; Robert R Henry
Journal:  Diabetologia       Date:  2017-08-02       Impact factor: 10.122

2.  G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia.

Authors:  Michele Ciccarelli; J Kurt Chuprun; Giuseppe Rengo; Erhe Gao; Zhengyu Wei; Raymond J Peroutka; Jessica I Gold; Anna Gumpert; Mai Chen; Nicholas J Otis; Gerald W Dorn; Bruno Trimarco; Guido Iaccarino; Walter J Koch
Journal:  Circulation       Date:  2011-04-25       Impact factor: 29.690

3.  Alteration of mitochondrial function in adult rat offspring of malnourished dams.

Authors:  Brigitte Reusens; Nicolas Theys; Claude Remacle
Journal:  World J Diabetes       Date:  2011-09-15

Review 4.  Physiological insights gained from gene expression analysis in obesity and diabetes.

Authors:  Mark P Keller; Alan D Attie
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

Review 5.  β-Arrestins: multifunctional signaling adaptors in type 2 diabetes.

Authors:  Xiaotao Feng; Wenjian Wang; Jibo Liu; Yi Liu
Journal:  Mol Biol Rep       Date:  2010-11-18       Impact factor: 2.316

Review 6.  Mitochondria in the pathogenesis of diabetes: a proteomic view.

Authors:  Xiulan Chen; Shasha Wei; Fuquan Yang
Journal:  Protein Cell       Date:  2012-06-22       Impact factor: 14.870

Review 7.  Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease.

Authors:  Jun Ren; Lakshmi Pulakat; Adam Whaley-Connell; James R Sowers
Journal:  J Mol Med (Berl)       Date:  2010-08-20       Impact factor: 4.599

Review 8.  The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome.

Authors:  François R Jornayvaz; Varman T Samuel; Gerald I Shulman
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

9.  BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis.

Authors:  Shu-Wen Qian; Yan Tang; Xi Li; Yuan Liu; You-You Zhang; Hai-Yan Huang; Rui-Dan Xue; Hao-Yong Yu; Liang Guo; Hui-Di Gao; Yan Liu; Xia Sun; Yi-Ming Li; Wei-Ping Jia; Qi-Qun Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-06       Impact factor: 11.205

10.  Relation of mitochondrial oxygen consumption in peripheral blood mononuclear cells to vascular function in type 2 diabetes mellitus.

Authors:  Mor-Li Hartman; Orian S Shirihai; Monika Holbrook; Guoquan Xu; Marsha Kocherla; Akash Shah; Jessica L Fetterman; Matthew A Kluge; Alissa A Frame; Naomi M Hamburg; Joseph A Vita
Journal:  Vasc Med       Date:  2014-02       Impact factor: 3.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.